End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,030 KRW | -0.40% | -2.33% | -12.67% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
Sales 2012 | 84.46B 61.41M | Sales 2013 * | - | Capitalization | 115B 83.62M |
---|---|---|---|---|---|
Net income 2012 * | - | Net income 2013 * | - | EV / Sales 2012 | 0.8 x |
Net cash position 2012 * | - 0 | Net cash position 2013 * | - 0 | EV / Sales 2013 * | - |
P/E ratio 2012 * |
-
| P/E ratio 2013 * |
-
| Employees | 290 |
Yield 2012 * |
-
| Yield 2013 * |
-
| Free-Float | 66.36% |
1 day | -0.40% | ||
1 week | -2.33% | ||
1 month | -3.64% | ||
3 months | -4.55% | ||
6 months | -18.08% | ||
Current year | -12.67% |
Managers | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Chan-Tae Ko
AUD | Comptroller/Controller/Auditor | 65 | - |
Bong-Rim Cho
PRN | Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Young-Ryul Lee
BRD | Director/Board Member | 66 | 19-03-28 |
Won-Gyoon Na
BRD | Director/Board Member | 38 | 22-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5,030 | -0.40% | 25,315 |
24-05-30 | 5,050 | -0.20% | 122,423 |
24-05-29 | 5,060 | -0.78% | 47,432 |
24-05-28 | 5,100 | -0.97% | 36,567 |
24-05-27 | 5,150 | -.--% | 46,244 |
End-of-day quote Korea S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.67% | 83.17M | |
+16.08% | 41.97B | |
+22.56% | 22.34B | |
+18.48% | 15.25B | |
+16.57% | 14B | |
+49.29% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A002210 Stock